Furthermore, in animals bearing peritoneal MC38 CRC, a novel oncolytic vv expressing the superagonist IL-15, a fusion protein of IL-15 and IL-15R-α(vvDD-IL15-Ra, IV administration) significantly reduced tumor growth and extended survival.71 This evidence concerns the gene IL15 and neoplasm.